Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settingsJacqueline S. Garcia, Robert J. Soiffer, Eric S. Winer et al.|Blood|2022Cited by 49
Phase 1b trial of tagraxofusp in combination with azacitidine with or without venetoclax in acute myeloid leukemiaAndrew A. Lane, Naveen Pemmaraju, Jacqueline S. Garcia et al.|Blood Advances|2023Cited by 45